Opioid Agonists/antagonists Flashcards
Opioid receptor
Serpentine molecule embedded in cell membrane
- 1 terminal ending exposed to extracellular envi
- other terminus is intracellular
Types of opioid receptors
Mu, Kappa, Delta, Sigma
Presynaptic function of opioid receptors
Inhibits neurotransmitter release (ACh, Dopamine, norepinephrine, substance P, GABA)
postsynaptic function of opioid receptors
Decreases neuronal excitability through hyperpolarization of cell membranes
Mu receptor subtypes
Analgesia (supraspinal & spinal)
Euphoria, ventilatory depression, bradycardia, urinary retention, physical dependence
Kappa subtype receptors
Analgesia (supraspinal & spinal)
Dysphoria, sedation, miosis
Delta subtypes receptors
Analgesia (supraspinal & spinal)
Ventilatory depression, urinary retention, modulation of Mu activity
Tissues for receptor distribution
Brain
Spinal cord
GIT
UIT
Synovium
Leukocytes
Uterus
Pure opioid agonist binding affinity
Produces dose-dependent increase in effect until max stimulation of receptor achieved
Effect increases as dose (or plasma concentration) increases until it plateaus at max effect
Partial opioid agonist binding affinity
Binding at given receptors causes an effect that is less pronounced than that of a pure agonist
Produces dose-dependent increase in effect, but plateaus at max effect less than max effect of full agonist
Opioid agonist-antagonist binding affinity
Causes stimulators effect at one receptor but blocks effect or causes less pronounced effect at another
Effects of these drugs depends on previous opioid exposure
Opioid antagonist affinity
Binds to receptor with high affinity & produces no effect
- reverses receptor mediated effects of agonists by inhibiting binding of agonist & displacing previously bound agonist due to greater receptor affinity of antagonist (competitive binding)
Full agonist classifications
Morphine, hydromorphone , methadone, oxymorphone, fentanyl
Partial agonist classifications
Buprenophine
Agonist-antagonist classifications
Butorphanol
Antagonist classifications
Naloxone, nalmefene, naltrexone
Different potency
Ex fentanyl and morphine have different potency meaning one will act quicker with less drug
Different efficacy
Ex morphine and buprenophine
Drugs given at same amount will have greater or less effect than the other
PD absorption considerations
Lipophilic /absorption rate
Bioavailability via SQ & IM
Low oral bioavailability
Transdermal absorption - fentanyl bypasses GIT and skips first pass hepatic effects
Transmucosal absorption - buprenorphine by passes first pass metabolism, variable absorption
PD considerations - distribution
Morphine is hydrophilic
P-glycoprotein efflux pumps limit CNS effects
- limit BBB crossing
- ex loperamide ->reduced central effects
PD considerations - mutations
Homozygous mutation in MDR1 gene
- BC, Aussie, GS, shetlands, sheepdogs, whippets
- significant central effects
- morphine, methadone, fentanyl, buprenophine, oxycodone